These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 16893327)

  • 1. Detection of HIV-1 in injection paraphernalia: risk in an era of heightened awareness.
    Page JB; Shapshak P; Duran EM; Even G; Moleon-Borodowski I; Llanusa-Cestero R
    AIDS Patient Care STDS; 2006 Aug; 20(8):576-85. PubMed ID: 16893327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of HIV-1 DNA in needle/syringes, paraphernalia, and washes from shooting galleries in Miami: a preliminary laboratory report.
    Shah SM; Shapshak P; Rivers JE; Stewart RV; Weatherby NL; Xin KQ; Page JB; Chitwood DD; Mash DC; Vlahov D; McCoy CB
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Mar; 11(3):301-6. PubMed ID: 8603266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in the "get-off": social process and intervention in risk locales.
    Page JB; Llanusa-Cestero R
    Subst Use Misuse; 2006; 41(6-7):1017-28. PubMed ID: 16809184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 transmission in injection paraphernalia: heating drug solutions may inactivate HIV-1.
    Clatts MC; Heimer R; Abdala N; Goldsamt LA; Sotheran JL; Anderson KT; Gallo TM; Hoffer LD; Luciano PA; Kyriakides T
    J Acquir Immune Defic Syndr; 1999 Oct; 22(2):194-9. PubMed ID: 10843535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
    Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
    MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Injection drug users' practices and attitudes toward intervention and potential for reducing the transmission of HIV.
    McCoy CB; Metsch LR; Page JB; McBride DC; Comerford ST
    Med Anthropol; 1997 Dec; 18(1):35-60. PubMed ID: 9458667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV risk behaviors associated with the injection process: multiperson use of drug injection equipment and paraphernalia in injection drug user networks.
    Needle RH; Coyle S; Cesari H; Trotter R; Clatts M; Koester S; Price L; McLellan E; Finlinson A; Bluthenthal RN; Pierce T; Johnson J; Jones TS; Williams M
    Subst Use Misuse; 1998 Oct; 33(12):2403-23. PubMed ID: 9781822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of needle exchange programs in HIV prevention.
    Vlahov D; Junge B
    Public Health Rep; 1998 Jun; 113 Suppl 1(Suppl 1):75-80. PubMed ID: 9722812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A certain fate: spread of HIV among young injecting drug users in Manipur, north-east India.
    Eicher AD; Crofts N; Benjamin S; Deutschmann P; Rodger AJ
    AIDS Care; 2000 Aug; 12(4):497-504. PubMed ID: 11091782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modelling the prevalence of HCV amongst people who inject drugs: an investigation into the risks associated with injecting paraphernalia sharing.
    Corson S; Greenhalgh D; Taylor A; Palmateer N; Goldberg D; Hutchinson S
    Drug Alcohol Depend; 2013 Nov; 133(1):172-9. PubMed ID: 23791029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of religiosity on HIV risk behaviors in active injection drug users.
    Hasnain M; Sinacore JM; Mensah EK; Levy JA
    AIDS Care; 2005 Oct; 17(7):892-901. PubMed ID: 16120505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coverage to curb the emerging HIV epidemic among injecting drug users in Pakistan: delivering prevention services where most needed.
    Emmanuel F; Fatima M
    Int J Drug Policy; 2008 Apr; 19 Suppl 1():S59-64. PubMed ID: 18281206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 RNA load in needles/syringes from shooting galleries in Miami: a preliminary laboratory report.
    Shapshak P; Fujimura RK; Page JB; Segal D; Rivers JE; Yang J; Shah SM; Graham G; Metsch L; Weatherby N; Chitwood DD; McCoy CB
    Drug Alcohol Depend; 2000 Feb; 58(1-2):153-7. PubMed ID: 10669066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cross-sectional study on factors including HIV testing and counselling determining unsafe injecting practices among injecting drug users of Manipur.
    Sarkar S; Panda S; Sarkar K; Hangzo CZ; Bijaya L; Singh NY; Das N; Agarwal A; Chatterjee A; Deb BC
    Indian J Public Health; 1995; 39(3):86-92. PubMed ID: 8690497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimal uptake of sterile drug preparation equipment in a predominantly cocaine injecting population: implications for HIV and hepatitis C prevention.
    Morissette C; Cox J; De P; Tremblay C; Roy E; Allard R; Stephenson R; Graves L
    Int J Drug Policy; 2007 May; 18(3):204-12. PubMed ID: 17689367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and correlates of indirect sharing practices among young adult injection drug users in five U.S. cities.
    Thiede H; Hagan H; Campbell JV; Strathdee SA; Bailey SL; Hudson SM; Kapadia F; Garfein RS;
    Drug Alcohol Depend; 2007 Nov; 91 Suppl 1():S39-47. PubMed ID: 17466464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in injecting practices associated with the use of a medically supervised safer injection facility.
    Stoltz JA; Wood E; Small W; Li K; Tyndall M; Montaner J; Kerr T
    J Public Health (Oxf); 2007 Mar; 29(1):35-9. PubMed ID: 17229788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 prevention: interdisciplinary studies on the efficacy of bleach and development of prevention protocols.
    McCoy CB; Shapshak P; Metsch LR; Rivers JE; McCoy HV; Weatherby NL; Shah SM; Chitwood DD
    Arch Immunol Ther Exp (Warsz); 1995; 43(1):1-9. PubMed ID: 8744677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Socio-behavioral and geographic correlates of prevalent hepatitis C virus infection among young injection drug users in metropolitan Baltimore and Chicago.
    Boodram B; Golub ET; Ouellet LJ
    Drug Alcohol Depend; 2010 Sep; 111(1-2):136-45. PubMed ID: 20472373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimation of the number of injecting drug users attending an outreach syringe-exchange program and infection with human immunodeficiency virus (HIV) and hepatitis C virus: the AjUDE-Brasil project.
    Caiaffa WT; Mingoti SA; Proietti FA; Carneiro-Proietti AB; Silva RC; Lopes AC; Doneda D
    J Urban Health; 2003 Mar; 80(1):106-14. PubMed ID: 12612100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.